VEA

Virtus ETF Advisers Portfolio holdings

AUM $75.7M
1-Year Return 23.01%
This Quarter Return
+25.81%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
AUM
$241M
AUM Growth
+$50.3M
Cap. Flow
+$11.6M
Cap. Flow %
4.82%
Top 10 Hldgs %
9.37%
Holding
372
New
47
Increased
146
Reduced
160
Closed
17

Sector Composition

1 Healthcare 29.53%
2 Real Estate 18.96%
3 Energy 16.61%
4 Materials 11.31%
5 Utilities 7.08%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
CDXS icon
176
Codexis
CDXS
$218M
$342K 0.14%
+15,659
New +$342K
EIDX
177
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$342K 0.14%
2,601
-4,144
-61% -$545K
IBRX icon
178
ImmunityBio
IBRX
$2.27B
$338K 0.14%
+25,388
New +$338K
MYOV
179
DELISTED
Myovant Sciences Ltd.
MYOV
$338K 0.14%
12,236
-6,088
-33% -$168K
EDIT icon
180
Editas Medicine
EDIT
$248M
$336K 0.14%
4,798
-6,619
-58% -$464K
ITOS
181
DELISTED
iTeos Therapeutics
ITOS
$335K 0.14%
+9,916
New +$335K
MAIN icon
182
Main Street Capital
MAIN
$5.95B
$334K 0.14%
10,341
-1,034
-9% -$33.4K
KOD icon
183
Kodiak Sciences
KOD
$556M
$333K 0.14%
2,268
-3,048
-57% -$448K
RGNX icon
184
Regenxbio
RGNX
$490M
$333K 0.14%
7,339
-1,420
-16% -$64.4K
BCSF icon
185
Bain Capital Specialty
BCSF
$1.02B
$330K 0.14%
27,202
-5,022
-16% -$60.9K
IMTX icon
186
Immatics
IMTX
$761M
$329K 0.14%
+30,508
New +$329K
PGEN icon
187
Precigen
PGEN
$1.3B
$326K 0.14%
+31,962
New +$326K
STOK icon
188
Stoke Therapeutics
STOK
$1.13B
$326K 0.14%
+5,264
New +$326K
APLS icon
189
Apellis Pharmaceuticals
APLS
$3.55B
$324K 0.13%
5,668
-4,279
-43% -$245K
NGM
190
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$324K 0.13%
10,685
-4,195
-28% -$127K
TCRR
191
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$324K 0.13%
+10,491
New +$324K
NSL
192
DELISTED
NUVEEN SENIOR INCM FD
NSL
$323K 0.13%
62,152
-8,488
-12% -$44.1K
ARNA
193
DELISTED
Arena Pharmaceuticals Inc
ARNA
$323K 0.13%
4,202
-832
-17% -$64K
ALXO icon
194
ALX Oncology
ALXO
$65.3M
$318K 0.13%
+3,688
New +$318K
KRTX
195
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$317K 0.13%
3,122
-200
-6% -$20.3K
JRO
196
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
$317K 0.13%
36,603
-5,354
-13% -$46.4K
RIGL icon
197
Rigel Pharmaceuticals
RIGL
$742M
$316K 0.13%
9,036
-8,088
-47% -$283K
JFR icon
198
Nuveen Floating Rate Income Fund
JFR
$1.13B
$314K 0.13%
35,910
-5,015
-12% -$43.9K
DSU icon
199
BlackRock Debt Strategies Fund
DSU
$547M
$313K 0.13%
29,951
-1,570
-5% -$16.4K
RETA
200
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$309K 0.13%
2,498
+605
+32% +$74.8K